1. Zhao, Xueying, Chen, Jin, Yin, Shangqi, Yuan, Zhengrong, Wang, Yajie. 2022. The expression of cuproptosis-related genes in hepatocellular carcinoma and their relationships with prognosis. In Frontiers in oncology, 12, 992468. doi:10.3389/fonc.2022.992468. https://pubmed.ncbi.nlm.nih.gov/36313717/
2. Lan, Danfeng, Wang, Junyu, Sun, Guishun, Wang, Yibo, Wu, Bian. 2024. Abnormal upregulation of NUBP2 contributes to cancer progression in colorectal cancer. In Molecular and cellular biochemistry, 480, 399-410. doi:10.1007/s11010-024-04956-8. https://pubmed.ncbi.nlm.nih.gov/38492158/
3. Ji, Minmin, Lv, Yuesheng, Chen, Chaoqun, Zhang, Wenjing, Li, Xiaojie. 2022. Metformin inhibits oral squamous cell carcinoma progression through regulating RNA alternative splicing. In Life sciences, 315, 121274. doi:10.1016/j.lfs.2022.121274. https://pubmed.ncbi.nlm.nih.gov/36509195/
4. Shao, Zheng, Lu, Lingling, Cui, Yongshi, Chen, Jv, Situ, Yongli. . PYCR in Kidney Renal Papillary Cell Carcinoma: Expression, Prognosis, Gene Regulation Network, and Regulation Targets. In Frontiers in bioscience (Landmark edition), 27, 336. doi:10.31083/j.fbl2712336. https://pubmed.ncbi.nlm.nih.gov/36624948/